Puerarin attenuates pressure overload-induced cardiac hypertrophy

Journal of Cardiology

Volumn 63, Issue 1, 2014, Pages 73-81

  Yuan, Yuan ^a,b   Zong, Jing ^a,b   Zhou, Heng ^a,b   Bian, Zhou Yan ^a,b   Deng, Wei ^a,b   Dai, Jia ^a,b   Gan, Hua Wen ^a,b   Yang, Zheng ^a,b   Li, Hongliang ^a,b   Tang, Qi Zhu ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Aortic coarctation; Hypertrophy; Pharmacology

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; DNA NUCLEOTIDYLEXOTRANSFERASE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PUERARIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA BANDING; AORTA SURGERY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIET; DISEASE COURSE; DRUG INDUSTRY; ECHOCARDIOGRAPHY; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC ASSOCIATION; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEMODYNAMIC PARAMETERS; HYPERTROPHY; MALE; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AORTIC COARCTATION; HYPERTROPHY; PHARMACOLOGY;

ADMINISTRATION, ORAL; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARDIOMEGALY; CARDIOTONIC AGENTS; CELLS, CULTURED; DISEASE PROGRESSION; FIBROSIS; GENE EXPRESSION; HEART FAILURE; ISOFLAVONES; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHATIDYLINOSITOL 3-KINASES; PHYTOTHERAPY; PRESSURE; VASODILATOR AGENTS;

EID: 84891902647     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.06.008     Document Type: Article

References (43)

1. Kutsuzawa D., Arimoto T., Watanabe T., Shishido T., Miyamoto T., Miyashita T., Takahashi H., Niizeki T., Takeishi Y., Kubota I. Ongoing myocardial damage in patients with heart failure and preserved ejection fraction. J Cardiol 2012, 60:454-461.
2. Gjesdal O., Bluemke D.A., Lima J.A. Cardiac remodeling at the population level - risk factors, screening, and outcomes. Nat Rev Cardiol 2011, 8:673-685.
3. Rouleau J.L. New and emerging drugs and device therapies for chronic heart failure in patients with systolic ventricular dysfunction. Can J Cardiol 2011, 27:296-301.
4. Hellawell J.L., Margulies K.B. Myocardial reverse remodeling. Cardiovasc Ther 2012, 30:172-181.
5. Tamargo J., Lopez-Sendon J. Novel therapeutic targets for the treatment of heart failure. Nat Rev Drug Discov 2011, 10:536-555.
6. Yao X.J., Yin J.A., Xia Y.F., Wei Z.F., Luo Y.B., Liu M., Feleder C., Dai Y. Puerarin exerts antipyretic effect on lipopolysaccharide-induced fever in rats involving inhibition of pyrogen production from macrophages. J Ethnopharmacol 2012, 141:322-330.
7. Wong K.H., Li G.Q., Li K.M., Razmovski-Naumovski V., Chan K. Kudzu root: traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases. J Ethnopharmacol 2011, 134:584-607.
8. Liu C.M., Ma J.Q., Sun Y.Z. Protective role of puerarin on lead-induced alterations of the hepatic glutathione antioxidant system and hyperlipidemia in rats. Food Chem Toxicol 2011, 49:3119-3127.
9. Choo M.K., Park E.K., Yoon H.K., Kim D.H. Antithrombotic and antiallergic activities of daidzein, a metabolite of puerarin and daidzin produced by human intestinal microflora. Biol Pharm Bull 2002, 25:1328-1332.
10. Huang F., Liu K., Du H., Kou J., Liu B. Puerarin attenuates endothelial insulin resistance through inhibition of inflammatory response in an IKKbeta/IRS-1-dependent manner. Biochimie 2012, 94:1143-1150.
11. Zhang H., Zhang L., Zhang Q., Yang X., Yu J., Shun S., Wu Y., Zeng Q., Wang T. Puerarin: a novel antagonist to inward rectifier potassium channel (IK1). Mol Cell Biochem 2011, 352:117-123.
12. Liu C.M., Ma J.Q., Sun Y.Z. Puerarin protects rat kidney from lead-induced apoptosis by modulating the PI3K/Akt/eNOS pathway. Toxicol Appl Pharmacol 2012, 258:330-342.
13. He H., Shi M., Yang J., Zeng X., Qiao H., Wu L., Li L. The correlation between angiogenesis and abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure, and improvement by puerarin. Phytother Res 2008, 22:948-956.
14. Zhang N.B., Huang Z.G., Cui W.D., Ding B.P. Effects of puerarin on expression of cardiac Smad3 and Smad7 mRNA in spontaneously hypertensive rat. J Ethnopharmacol 2011, 138:737-740.
15. Chen R., Xue J., Xie M. Puerarin prevents isoprenaline-induced myocardial fibrosis in mice by reduction of myocardial TGF-beta1 expression. J Nutr Biochem 2012, 23:1080-1085.
16. Tanaka T., Tang H., Yu F., Michihara S., Uzawa Y., Zaima N., Moriyama T., Kawamura Y. Kudzu (Pueraria lobata) vine ethanol extracts improve ovariectomy-induced bone loss in female mice. J Agric Food Chem 2011, 59:13230-13237.
17. Shu C., Chen C., Zhang D.P., Guo H., Zhou H., Zong J., Bian Z., Dong X., Dai J., Zhang Y., Tang Q. Gastrodin protects against cardiac hypertrophy and fibrosis. Mol Cell Biochem 2012, 359:9-16.
18. Yan L., Wei X., Tang Q.Z., Feng J., Zhang Y., Liu C., Bian Z.Y., Zhang L.F., Chen M., Bai X., Wang A.B., Fassett J., Chen Y., He Y.W., Yang Q., et al. Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3beta and TGF-beta1-Smad signalling. Cardiovasc Res 2011, 92:85-94.
19. Tang X.L., Liu X.J., Tian Q., Zhang W. Dynamic oxidative stress and DNA damage induced by oestrogen deficiency and protective effects of puerarin and 17 beta-oestradiol in ovariectomized rats. Basic Clin Pharmacol Toxicol 2012, 111:87-91.
20. Wang Q., Wu T., Chen X., Ni J., Duan X., Zheng J., Qiao J., Zhou L., Wei J. Puerarin injection for unstable angina pectoris. Cochrane Database Syst Rev 2006, CD004196.
21. Fan D., Takawale A., Lee J., Kassiri Z. Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair 2012, 5:15.
22. de Jong S., van Veen T.A., de Bakker J.M., Vos M.A., van Rijen H.V. Biomarkers of myocardial fibrosis. J Cardiovasc Pharmacol 2011, 57:522-535.
23. Zhang S., Ji G., Liu J. Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin. J Nutr Biochem 2006, 17:485-491.
24. Zhou H., Bian Z.Y., Zong J., Deng W., Yan L., Shen D.F., Guo H., Dai J., Yuan Y., Zhang R., Lin Y.F., Hu X., Li H., Tang Q.Z. Stem cell antigen 1 protects against cardiac hypertrophy and fibrosis after pressure overload. Hypertension 2012, 60:802-809.
25. Kassiri Z., Defamie V., Hariri M., Oudit G.Y., Anthwal S., Dawood F., Liu P., Khokha R. Simultaneous transforming growth factor beta-tumor necrosis factor activation and cross-talk cause aberrant remodeling response and myocardial fibrosis in Timp3-deficient heart. J Biol Chem 2009, 284:29893-29904.
26. Koitabashi N., Arai M., Kogure S., Niwano K., Watanabe A., Aoki Y., Maeno T., Nishida T., Kubota S., Takigawa M., Kurabayashi M. Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension 2007, 49:1120-1127.
27. Meems L.M., Cannon M.V., Mahmud H., Voors A.A., van Gilst W.H., Sillje H.H., Ruifrok W.P., de Boer R.A. The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload. J Steroid Biochem Mol Biol 2012, 132:282-289.
28. Shioi T., Inuzuka Y. Aging as a substrate of heart failure. J Cardiol 2012, 60:423-428.
29. Vanhaesebroeck B., Guillermet-Guibert J., Graupera M., Bilanges B. The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol 2010, 11:329-341.
30. Chaanine A.H., Hajjar R.J. AKT signalling in the failing heart. Eur J Heart Fail 2011, 13:825-829.
31. Badorff C., Ruetten H., Mueller S., Stahmer M., Gehring D., Jung F., Ihling C., Zeiher A.M., Dimmeler S. Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload. J Clin Invest 2002, 109:373-381.
32. Haq S., Choukroun G., Kang Z.B., Ranu H., Matsui T., Rosenzweig A., Molkentin J.D., Alessandrini A., Woodgett J., Hajjar R., Michael A., Force T. Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy. J Cell Biol 2000, 151:117-130.
33. Kurdi M., Booz G.W. Three 4-letter words of hypertension-related cardiac hypertrophy: TRPC, mTOR, and HDAC. J Mol Cell Cardiol 2011, 50:964-971.
34. Shioi T., McMullen J.R., Tarnavski O., Converso K., Sherwood M.C., Manning W.J., Izumo S. Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 2003, 107:1664-1670.
35. Skurk C., Izumiya Y., Maatz H., Razeghi P., Shiojima I., Sandri M., Sato K., Zeng L., Schiekofer S., Pimentel D., Lecker S., Taegtmeyer H., Goldberg A.L., Walsh K. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling. J Biol Chem 2005, 280:20814-20823.
36. Ronnebaum S.M., Patterson C. The FoxO family in cardiac function and dysfunction. Annu Rev Physiol 2010, 72:81-94.
37. Cai W.F., Zhang X.W., Yan H.M., Ma Y.G., Wang X.X., Yan J., Xin B.M., Lv X.X., Wang Q.Q., Wang Z.Y., Yang H.Z., Hu Z.W. Intracellular or extracellular heat shock protein 70 differentially regulates cardiac remodelling in pressure overload mice. Cardiovasc Res 2010, 88:140-149.
38. Esposito G., Prasad S.V., Rapacciuolo A., Mao L., Koch W.J., Rockman H.A. Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload. Circulation 2001, 103:1453-1458.
39. Choudhary R., Palm-Leis A., Scott R.C., Guleria R.S., Rachut E., Baker K.M., Pan J. All-trans retinoic acid prevents development of cardiac remodeling in aortic banded rats by inhibiting the renin-angiotensin system. Am J Physiol Heart Circ Physiol 2008, 294:H633-H644.
40. Fan G.C., Yuan Q., Song G., Wang Y., Chen G., Qian J., Zhou X., Lee Y.J., Ashraf M., Kranias E.G. Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1. Circ Res 2006, 99:1233-1242.
41. Wu C., Jin B., Chen L., Zhuo D., Zhang Z., Gong K., Mao Z. MiR-30d induces apoptosis and is regulated by the Akt/FOXO pathway in renal cell carcinoma. Cell Signal 2013, 25:1212-1221.
42. Ferdous A., Battiprolu P.K., Ni Y.G., Rothermel B.A., Hill J.A. FoxO, autophagy, and cardiac remodeling. J Cardiovasc Transl Res 2010, 3:355-364.
43. Chaanine A.H., Jeong D., Liang L., Chemaly E.R., Fish K., Gordon R.E., Hajjar R.J. JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure. Cell Death Dis 2012, 3:265.